Ehealth (EHTH) AI Stock Analysis

• Market Cap: $110.75M
• Dividend Yield: N/A
• Average Volume (3M): 372.71K
• Price to Earnings (P/E): 97.0
• Beta (1Y): 0.84
• Revenue Growth: 16.79%
• EPS Growth: N/A
• Country: US
• Employees: 1,773
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Brokers
• EPS (TTM): -1.12
• Shares Outstanding: 30,764,786
• 10 Day Avg. Volume: 371,368
• 30 Day Avg. Volume: 372,711
• PEG Ratio: -0.55
• Price to Book (P/B): 0.30
• Price to Sales (P/S): 0.52
• P/FCF Ratio: -8.83
• Enterprise Value/Market Cap: 4.69
• Enterprise Value/Revenue: 0.96
• Enterprise Value/Gross Profit: 0.96
• Enterprise Value/Ebitda: 7.26
• 1Y Price Target: $9.00
• Price Target Upside: 171.08% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 4
• EPS Forecast (FY): 1
• Revenue Forecast (FY): $546.99M

• Rating: 49 Neutral
• Price Target: $3.50 ▲(5.42% Upside)

Ehealth's overall stock score is primarily impacted by its financial performance and technical analysis. The company faces significant revenue decline and cash flow challenges, which are compounded by a bearish technical outlook. The high P/E ratio suggests overvaluation, further weighing down the score. Despite positive guidance from the earnings call, the lack of dividend yield and negative market momentum are key concerns.

Positive Factors

Technology Advancements

By leveraging advanced technology, eHealth enhances consumer experience and operational efficiency, potentially increasing user engagement and retention.

Improved Financial Guidance

The improved financial guidance reflects strong performance and strategic positioning, suggesting potential for enhanced profitability and shareholder value.

Strong Gross Profitability

A high gross profit margin indicates effective cost management and pricing power, which can support long-term financial stability and growth.

Negative Factors

Revenue Decline

The substantial revenue decline poses challenges to growth and sustainability, potentially impacting the company's ability to invest in future opportunities.

Negative Operating Cash Flow

Negative operating cash flow indicates cash management issues, which can strain liquidity and limit the company's ability to fund operations and growth initiatives.

Medicare Advantage Volume Challenges

Challenges in Medicare Advantage volume may hinder revenue growth and market share expansion, affecting long-term competitive positioning.

Ehealth Business Overview & Revenue Model

Company Description

eHealth, Inc. operates a health insurance marketplace that provides consumer engagement, education, and health insurance enrollment solutions in the United States. The company operates in two segments, Medicare; and Individual, Family and Small Business. Its ecommerce platforms organize and present health insurance information in various formats that enable individuals, families, and small businesses to research, analyze, compare, and purchase a range of health insurance plans. The company operates a marketplace that offers consumers a choice of insurance products, such as Medicare Advantage, Medicare Supplement, Medicare Part D prescription drug, individual and family, small business, and other ancillary health insurance products from health insurance carriers. It markets health insurance plans through its websites, including eHealth.com, eHealthInsurance.com, eHealthMedicare.com, Medicare.com, PlanPrescriber.com, and GoMedigap.com, as well as through a network of marketing partners. The company also licenses its health insurance ecommerce technology that enables health insurance carriers to market and distribute health insurance plans online; and provides online sponsorship and advertising, and lead referral services. eHealth, Inc. was incorporated in 1997 and is headquartered in Santa Clara, California.

How the Company Makes Money

Ehealth generates revenue primarily through commissions earned from insurance carriers for each policy sold through its platform. The company acts as an intermediary, facilitating the enrollment of customers into various health insurance plans and receiving a percentage of the premium paid by the insured. Additionally, Ehealth may earn revenue from lead generation services by providing potential customer data to insurance providers. The company's partnerships with numerous insurance carriers enhance its offerings and improve its competitive position in the market, while its online platform also allows for scalability and cost-efficiency in its operations.

Ehealth Financial Statement Overview

Summary

Ehealth's financial performance is mixed. The income statement shows improved profitability but declining revenue growth. The balance sheet is stable with low debt, but cash flow issues persist with negative operating and free cash flows. Overall, while profitability is a positive, revenue contraction and cash flow challenges are significant concerns.

Income Statement

Ehealth's income statement shows a mixed performance. The TTM data reveals a decline in revenue growth rate, indicating a contraction in sales. However, there is an improvement in profitability with a positive net profit margin and EBIT margin compared to previous periods. The gross profit margin remains strong, suggesting efficient cost management. Overall, while profitability metrics have improved, the negative revenue growth is a concern.

Balance Sheet

The balance sheet reflects a stable financial position with a low debt-to-equity ratio, indicating conservative leverage. The equity ratio is healthy, showing a strong capital base. Return on equity has improved but remains modest. Overall, the balance sheet suggests financial stability with limited risk from debt.

Cash Flow

Cash flow analysis highlights challenges with negative operating and free cash flows, although there is an improvement in free cash flow growth. The operating cash flow to net income ratio is negative, indicating cash flow issues despite reported net income. The free cash flow to net income ratio is high, suggesting reliance on non-operating cash flows. Overall, cash flow management remains a concern.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	542.95M	532.41M	452.87M	405.36M	538.20M	582.77M
Gross Profit	542.95M	530.62M	451.10M	403.71M	536.21M	578.69M
EBITDA	71.61M	46.81M	295.00K	-77.65M	-105.18M	66.27M
Net Income	50.34M	10.06M	-28.21M	-88.72M	-104.38M	45.45M
Balance Sheet
Total Assets	1.05B	1.16B	1.11B	1.11B	1.15B	1.04B
Cash, Cash Equivalents and Short-Term Investments	75.30M	82.24M	121.65M	144.40M	123.23M	93.38M
Total Debt	92.73M	96.92M	103.16M	106.80M	41.37M	46.56M
Total Liabilities	162.95M	567.00M	209.26M	461.66M	399.77M	202.46M
Stockholders Equity	884.47M	588.43M	904.08M	650.96M	749.52M	837.56M
Cash Flow
Free Cash Flow	-29.85M	-31.22M	-17.47M	-42.38M	-183.48M	-131.62M
Operating Cash Flow	-17.06M	-18.37M	-6.69M	-26.87M	-162.62M	-107.86M
Investing Cash Flow	27.04M	-48.42M	-15.89M	25.86M	-12.63M	-73.28M
Financing Cash Flow	-10.80M	-9.67M	-6.22M	63.84M	213.24M	201.25M

Ehealth Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 3.32
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EHTH, the sentiment is Negative. The current price of 3.32 is below the 20-day moving average (MA) of 4.48, below the 50-day MA of 4.45, and below the 200-day MA of 5.23, indicating a bearish trend. The MACD of -0.31 indicates Positive momentum. The RSI at 30.01 is Neutral, neither overbought nor oversold. The STOCH value of 5.72 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EHTH.

Ehealth Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
HUIZ	57 Neutral	$31.27M	12.74	4.56%	―	19.30%	-17.56%
SLQT	50 Neutral	$244.60M	―	15.11%	―	13.16%	―
EHTH	49 Neutral	$110.75M	97.04	5.88%	―	16.79%	―
RELI	43 Neutral	$7.11M	―	-146.43%	―	-6.84%	97.23%
TIRX	43 Neutral	$26.98M	-1.75	-11.18%	―	624.24%	85.46%
GOCO	41 Neutral	$65.80M	-0.14	-142.05%	―	7.56%	-344.04%

Ehealth Corporate Events

EHealth Inc. Earnings Call: Mixed Sentiment, Optimistic Guidance

The recent earnings call for eHealth Inc. presented a mixed sentiment, reflecting both positive advancements and ongoing challenges. The company highlighted improved financial guidance and technological advancements, alongside member retention strategies. However, these positives were tempered by issues such as challenges in Medicare Advantage volume and a decline in overall revenue. Despite these hurdles, eHealth’s proactive strategies and optimistic guidance suggest a cautiously positive outlook for the future.

eHealth, Inc. Reports Strong Q3 2025 Results

eHealth, Inc. is a prominent private online health insurance marketplace that connects millions of Americans with suitable healthcare coverage options from over 180 health insurers, including both national and regional companies.

eHealth Amends Credit Agreement with Blue Torch Finance

On October 6, 2025, eHealth, Inc. announced an amendment to its credit agreement with Blue Torch Finance LLC, extending the maturity date of its term loan to January 29, 2027. This extension is part of eHealth’s strategy to enhance its capital structure, providing financial flexibility to support its strategic initiatives and long-term success. The company aims to leverage its commissions receivable asset to increase capital access and address its convertible Series A preferred stock instrument, demonstrating a commitment to optimizing its capital structure and maximizing shareholder value.

The most recent analyst rating on (EHTH) stock is a Hold with a $5.50 price target. To see the full list of analyst forecasts on Ehealth stock, see the EHTH Stock Forecast page.

Ehealth Announces Board Changes with New Appointments

On September 17, 2025, Aaron Tolson resigned from the Board of Directors of eHealth, Inc., along with its various committees, and was replaced by Todd Arden, a designee of Echelon Health SPV, LP, under the terms of an existing Investment Agreement. Additionally, Derrick Duke was appointed as a new director, increasing the total number of directors from nine to ten. Both appointments are effective immediately and will last until the 2028 annual meeting of stockholders. These changes are part of the company’s ongoing governance adjustments, with no disagreements or undisclosed relationships involved.

The most recent analyst rating on (EHTH) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Ehealth stock, see the EHTH Stock Forecast page.